MIVOCELL Trademark

Trademark Overview


On Thursday, September 5, 2024, a trademark application was filed for MIVOCELL with the United States Patent and Trademark Office. The USPTO has given the MIVOCELL trademark a serial number of 98734979. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Tuesday, February 24, 2026. This trademark is owned by Kyverna Therapeutics, Inc.. The MIVOCELL trademark is filed in the Pharmaceutical Products category with the following description:

Therapeutic pharmaceuticals for the treatment of autoimmune diseases and cancer; therapeutic pharmaceuticals and cell therapy products in the nature of cells for medical or clinical use for the treatment of autoimmune disease and cancer; cell therapy products, namely, genetically engineered immune cells for medical or clinical use for the treatment of autoimmune disease and cancer; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparations and substances for the treatment of oncological and immune system related diseases and disorders
mivocell

General Information


Serial Number98734979
Word MarkMIVOCELL
Filing DateThursday, September 5, 2024
Status731 - SECOND EXTENSION - GRANTED
Status DateTuesday, February 24, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 18, 2025

Trademark Statements


Goods and ServicesTherapeutic pharmaceuticals for the treatment of autoimmune diseases and cancer; therapeutic pharmaceuticals and cell therapy products in the nature of cells for medical or clinical use for the treatment of autoimmune disease and cancer; cell therapy products, namely, genetically engineered immune cells for medical or clinical use for the treatment of autoimmune disease and cancer; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparations and substances for the treatment of oncological and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 5, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKyverna Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEmeryville, CA 94608
US

Party NameKyverna Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEmeryville, CA 94608
US

Trademark Events


Event DateEvent Description
Thursday, September 5, 2024NEW APPLICATION ENTERED
Thursday, September 5, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 15, 2025ASSIGNED TO EXAMINER
Monday, January 27, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 12, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 18, 2025PUBLISHED FOR OPPOSITION
Tuesday, February 18, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 15, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, September 10, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, September 10, 2025SOU EXTENSION 1 FILED
Wednesday, September 10, 2025SOU EXTENSION 1 GRANTED
Thursday, September 11, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 24, 2026SOU TEAS EXTENSION RECEIVED
Tuesday, February 24, 2026SOU EXTENSION 2 FILED
Tuesday, February 24, 2026SOU EXTENSION 2 GRANTED
Wednesday, February 25, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED